← Leaderboards
Tomasz Cierpicki
University Of Michigan At Ann Arbor
$10,333,927
Attributed
$10,346,426
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,346,426 · 7
By mechanism
R01$10,321,427 · 6
R03$24,999 · 1
Top collaborators
- Jolanta Grembecka1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Stephen P. Ethier$7,520,872
- Jolanta Grembecka$12,187,788
- Sami Nimer Malek$8,691,121
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeStructureDesignScreeningIn VivoBindingSmall Molecule InhibitorReportingAnimal ModelMalignant NeoplasmsCellsComplexStructural BiologyAffinityBaseInnovationOncogenicChromatinDrug KineticsAnalogProteinsPharmaceutical ChemistryEpigenetic ProcessProperty
Grant awards (23)
Targeting PRC1 in leukemia$624,980
R01 · FY2025 · CA · contact PI
Development of chemical probe targeting NSD3 SET domain in breast cancer$572,327
R01 · FY2025 · CA · contact PI
Targeting PRC1 in leukemia$593,733
R01 · FY2024 · CA · contact PI
Development of chemical probe targeting NSD3 SET domain in breast cancer$572,327
R01 · FY2024 · CA · contact PI
Targeting PRC1 in leukemia$624,980
R01 · FY2023 · CA · contact PI
Targeting epigenetic reader GAS41$497,243
R01 · FY2023 · CA · contact PI
Targeting NSD1 in leukemia$441,957
R01 · FY2023 · CA · contact PI
Targeting epigenetic reader GAS41$497,243
R01 · FY2022 · CA · contact PI
Targeting NSD1 in leukemia$442,141
R01 · FY2022 · CA · contact PI
Targeting epigenetic reader GAS41$504,038
R01 · FY2021 · CA · contact PI
Targeting NSD1 in leukemia$464,783
R01 · FY2021 · CA · contact PI
Targeting epigenetic reader GAS41$528,041
R01 · FY2020 · CA · contact PI
Targeting NSD1 in leukemia$472,928
R01 · FY2020 · CA · contact PI
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia$402,747
R01 · FY2020 · CA · contact PI
Targeting NSD1 in leukemia$484,924
R01 · FY2019 · CA · contact PI
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia$390,664
R01 · FY2019 · CA · contact PI
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia$415,301
R01 · FY2018 · CA · contact PI
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia$410,649
R01 · FY2017 · CA · contact PI
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia$428,258
R01 · FY2016 · CA · contact PI
Inhibition of CDC25B phosphatase by targeting protein-protein interactions$316,863
R01 · FY2016 · CA · contact PI
Inhibition of CDC25B phosphatase by targeting protein-protein interactions$317,443
R01 · FY2015 · CA · contact PI
Inhibition of CDC25B phosphatase by targeting protein-protein interactions$317,857
R01 · FY2014 · CA · contact PI
Screening for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leuke$24,999
R03 · FY2008 · MH